Precision BioSciences

In News

Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 - Precision BioSciences

Precision BioSciences - Aug 14, 2026

Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study - Business Wire

Business Wire - Aug 24, 2026

Precision BioSciences doses first patient in Phase 1/2 FUNCTION-DMD gene-editing trial - Dealroom

Dealroom - Aug 25, 2026

Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake - Stock Titan

Stock Titan - Aug 24, 2026

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 - Yahoo Finance

Yahoo Finance - Jul 31, 2026

Precision BioSciences doses first patient in DMD gene editing trial - Investing.com

Investing.com - Aug 24, 2026

Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) - Seeking Alpha

Seeking Alpha - Aug 18, 2026

FDA Clears ARCUS Editor for Duchenne Hot-spot - CRISPR Medicine News

CRISPR Medicine News - Feb 18, 2026

Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences - European AIDS Treatment Group

European AIDS Treatment Group - Apr 15, 2026

Precision BioSciences (DTIL) Short Interest & Short Float | Updated Aug 2026 $DTIL - MarketBeat

MarketBeat - Aug 25, 2026

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - Yahoo Finance

Yahoo Finance - Jul 27, 2026

Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - Precision BioSciences

Precision BioSciences - Oct 07, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment